MedPath
NMPA Approval

fufang danshen tablet

国药准字Z21021734

January 7, 2021

Drug Information

复方丹参片

片剂

每片含丹参以丹参酮ⅡA(C19H18O3)计,不得少于0.20mg。

中药

January 7, 2021

Company Information

Applicant Company

Manufacturing Company

辽宁省抚顺市东洲区兰山经济开发区(大治一沟)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方丹参片 - NMPA 批准文号 | MedPath